Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. While treatments developed for women with breast cancer are often …

Background The overall incidence of male breast cancer is around 1% of all breast cancers
and is on the rise. In this review we aim to present various aspects of male breast cancer …

The incidence of male breast cancer (MBC) is rising; however, mortality due to MBC has not
changed, unlike female breast cancer. This lack of change is mostly attributable to a lack of …

Male breast cancer is a rare disease for which treatment has been based on the evidence
available from female breast cancer. The new genomic tools can better characterize the …

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …